The current valuation score of Evolus Inc is 8.03, ranking 75 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is -8.74, which is -48.03% below the recent high of -4.54 and -121.00% above the recent low of -19.32.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.